US EditionPancreatic Cancer Organoids Derived From EUS-Guided Fine Needle Aspiration Specimens Can Be Used to Predict Chemotherapy Resistance
4 Articles
4 Articles
Pancreatic cancer organoids derived from EUS-guided fine needle aspiration specimens can be used to predict chemotherapy resistance
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. Although chemotherapy has become increasingly important in recent years, there are no practical markers to predict therapeutic efficacy. Here, we have aimed to identify novel markers that predict resistance to chemotherapy drugs using patient-derived organoids (PDOs) of PDAC. PDOs were established using endoscopic ultrasound - guided fine needle aspiration (EUS-FNA) specimens. Drug se…
The Pancreatic Cancer Action Network Announces Leadership Updates to its Board of Directors and Scientific Medical Advisory Board for FY2026
Jul 7, 2025 - By Charaighn SesockLOS ANGELES, CALIF. – (July 7, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments and transitions to its Fiscal Year 2026 Board of Directors and Scientific and Medical Advisory Board (SMAB), effective July 1, 2025. Joining the Board this year is Jon Mahrt, Chief Executive Officer of Optum Rx and Chi…
Pancreatic cancer, known for its insidious progression, is a serious disease that is difficult to diagnose and is usually noticed in advanced stages. Malignant cell proliferations that develop in any part of the pancreas are defined as pancreatic cancer. eki, what is pancreatic cancer? What are its symptoms?
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
